Display Settings:

Format

Send to:

Choose Destination
Indian J Pharmacol. 2012 Sep-Oct;44(5):599-601. doi: 10.4103/0253-7613.100384.

Nimesulide inhibits the proliferation of HepG2 by up-regulation of Smad4.

Author information

  • 1Department of Gastroenterology, The Affiliated Hospital of NingXia Medical University, Yinchuan 750004, China.

Abstract

OBJECTIVES:

Hepatocellular carcinoma (HCC) is receiving increased attention. This study was designed to investigate the effect of selective Cyclooxygenase-2 (COX-2) inhibitor, nimesulide, on the expression of Smad4 in human hepatocellular carcinoma HepG2.

MATERIALS AND METHODS:

HepG2 cells were incubated in various concentrations of nimesulide (25, 50, 100, 200, 400 ╬╝mol/L) to detect the effect of proliferation by MTS. The apoptosis of HepG2 was determined by TUNEL; fluorescence microscope was used to observe the expression of Smad4.

RESULTS:

The result showed that nimesulide inhibited the proliferation of HepG2 cell in a concentrations-dependent manner, and promoted the karyopyknosis and fragmentation of HepG2 cell nucleus, induced its apoptosis, the number of fluorescence labeling of Smad4 in Nimesulide group was higher than control group (P<0.05).

CONCLUSIONS:

Nimesulide inhibits the proliferation and promotes apoptosis of HepG2 by up-regulation of Smad4 in HepG2.

KEYWORDS:

Hepatic carcinoma cell; Nimesulide; Smad4

PMID:
23112421
[PubMed - indexed for MEDLINE]
PMCID:
PMC3480792
Free PMC Article

Images from this publication.See all images (3)Free text

Figure 1
Figure 2
Figure 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
    Loading ...
    Write to the Help Desk